These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20027223)

  • 21. Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting.
    Jönsson F; Hagedorn C; Kreppel F
    J Vis Exp; 2018 Oct; (140):. PubMed ID: 30417881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting of adenoviral vectors through a bispecific single-chain antibody.
    Haisma HJ; Grill J; Curiel DT; Hoogeland S; van Beusechem VW; Pinedo HM; Gerritsen WR
    Cancer Gene Ther; 2000 Jun; 7(6):901-4. PubMed ID: 10880021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Capsomer-specific fluorescent labeling of adenoviral vector particles allows for detailed analysis of intracellular particle trafficking and the performance of bioresponsive bonds for vector capsid modifications.
    Espenlaub S; Corjon S; Engler T; Fella C; Ogris M; Wagner E; Kochanek S; Kreppel F
    Hum Gene Ther; 2010 Sep; 21(9):1155-67. PubMed ID: 20384482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel capsid-modified oncolytic recombinant adenovirus type 5 for tumor-targeting gene therapy by intravenous route.
    Wang Z; Yu B; Wang B; Yan J; Feng X; Wang Z; Wang L; Zhang H; Wu H; Wu J; Kong W; Yu X
    Oncotarget; 2016 Jul; 7(30):47287-47301. PubMed ID: 27323824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimization of capsid-incorporated antigens for a novel adenovirus vaccine approach.
    Matthews QL; Yang P; Wu Q; Belousova N; Rivera AA; Stoff-Khalili MA; Waehler R; Hsu HC; Li Z; Li J; Mountz JD; Wu H; Curiel DT
    Virol J; 2008 Aug; 5():98. PubMed ID: 18718011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reductive amination as a strategy to reduce adenovirus vector promiscuity by chemical capsid modification with large polysaccharides.
    Espenlaub S; Wortmann A; Engler T; Corjon S; Kochanek S; Kreppel F
    J Gene Med; 2008 Dec; 10(12):1303-14. PubMed ID: 18837065
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modification of adenovirus capsid with a designed protein ligand yields a gene vector targeted to a major molecular marker of cancer.
    Belousova N; Mikheeva G; Gelovani J; Krasnykh V
    J Virol; 2008 Jan; 82(2):630-7. PubMed ID: 17989185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Targeted inhibition of rabies virus replication in vitro by single chain antibody domain mediated vector expression shRNA delivery].
    Yang R; Cui Y; Yang S; Wang C; Shan H; Wang H; Xia X
    Wei Sheng Wu Xue Bao; 2010 Feb; 50(2):256-62. PubMed ID: 20387470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic incorporation of a herpes simplex virus type 1 thymidine kinase and firefly luciferase fusion into the adenovirus protein IX for functional display on the virion.
    Matthews QL; Sibley DA; Wu H; Li J; Stoff-Khalili MA; Waehler R; Mathis JM; Curiel DT
    Mol Imaging; 2006; 5(4):510-9. PubMed ID: 17150163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenoviral targeting using genetically incorporated camelid single variable domains.
    Kaliberov SA; Kaliberova LN; Buggio M; Tremblay JM; Shoemaker CB; Curiel DT
    Lab Invest; 2014 Aug; 94(8):893-905. PubMed ID: 24933423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting of adenovirus to endothelial cells by a bispecific single-chain diabody directed against the adenovirus fiber knob domain and human endoglin (CD105).
    Nettelbeck DM; Miller DW; Jérôme V; Zuzarte M; Watkins SJ; Hawkins RE; Müller R; Kontermann RE
    Mol Ther; 2001 Jun; 3(6):882-91. PubMed ID: 11407902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein.
    Stevenson SC; Rollence M; Marshall-Neff J; McClelland A
    J Virol; 1997 Jun; 71(6):4782-90. PubMed ID: 9151872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, expression and characterization of single chain Fv, Mms13 and the single chain Fv‑mms13 fusion protein.
    Kong D; Wang X; Wang X; Wang X; Chen X; Ji G; Fu X; Wang S
    Mol Med Rep; 2015 Jul; 12(1):1213-8. PubMed ID: 25824464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Development of a Recombinant scFv Monoclonal Antibody Targeting Canine CD20 for Use in Comparative Medicine.
    Jain S; Aresu L; Comazzi S; Shi J; Worrall E; Clayton J; Humphries W; Hemmington S; Davis P; Murray E; Limeneh AA; Ball K; Ruckova E; Muller P; Vojtesek B; Fahraeus R; Argyle D; Hupp TR
    PLoS One; 2016; 11(2):e0148366. PubMed ID: 26894679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complex mosaicism is a novel approach to infectivity enhancement of adenovirus type 5-based vectors.
    Borovjagin AV; Krendelchtchikov A; Ramesh N; Yu DC; Douglas JT; Curiel DT
    Cancer Gene Ther; 2005 May; 12(5):475-86. PubMed ID: 15706356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Secretory signal peptide modification for optimized antibody-fragment expression-secretion in Leishmania tarentolae.
    Klatt S; Konthur Z
    Microb Cell Fact; 2012 Jul; 11():97. PubMed ID: 22830363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modifications of the fiber in adenovirus vectors increase tropism for malignant glioma models.
    Staba MJ; Wickham TJ; Kovesdi I; Hallahan DE
    Cancer Gene Ther; 2000 Jan; 7(1):13-9. PubMed ID: 10678351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob.
    Mizuguchi H; Koizumi N; Hosono T; Utoguchi N; Watanabe Y; Kay MA; Hayakawa T
    Gene Ther; 2001 May; 8(9):730-5. PubMed ID: 11406768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting of high-capacity adenoviral vectors.
    Biermann V; Volpers C; Hussmann S; Stock A; Kewes H; Schiedner G; Herrmann A; Kochanek S
    Hum Gene Ther; 2001 Sep; 12(14):1757-69. PubMed ID: 11560769
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting EGFR with metabolically biotinylated fiber-mosaic adenovirus.
    Pereboeva L; Komarova S; Roth J; Ponnazhagan S; Curiel DT
    Gene Ther; 2007 Apr; 14(8):627-37. PubMed ID: 17251987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.